Influence of branched ligand architectures on nanoparticle interactions with lipid bilayers
Nanoscale · 2025
DOI: 10.1039/d4nr03848g ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Carlos A Huang-Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA. vanlehn@wisc.edu. Hauptthemen laut MEDLINE: Lipid Bilayers, Gold, Metal Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, University of Wisconsin-Madison, National Institute of General Medical Sciences.
Abstract (Originalsprache)
We utilize coarse-grained molecular dynamics simulations and enhanced sampling methods to reveal the effect of ligand branching on the thermodynamics of nanoparticle adsorption to lipid bilayers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA. vanlehn@wisc.edu.
- Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Förderung
- NIGMS NIH HHS
- University of Wisconsin-Madison
- National Institute of General Medical Sciences
- National Science Foundation
- Office of Advanced Cyberinfrastructure
Zitieren
APA
Huang-Zhu, C. A., & Van Lehn, R. C. (2025). Influence of branched ligand architectures on nanoparticle interactions with lipid bilayers. Nanoscale. https://doi.org/10.1039/d4nr03848g
Vancouver
Huang-Zhu CA, Van Lehn RC. Influence of branched ligand architectures on nanoparticle interactions with lipid bilayers. Nanoscale. 2025. doi:10.1039/d4nr03848g
BibTeX
@article{HuangZhu2025,
author = {Huang-Zhu, Carlos A and Van Lehn, Reid C},
title = {Influence of branched ligand architectures on nanoparticle interactions with lipid bilayers},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d4nr03848g}
}
EUVIMED